Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bousquet

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Cancer Research|March 1, 1990
Effects of cytochalasin B in culture and in vivo on murine Madison 109 lung carcinoma and on B16 melanomaP F Bousquet, L A Paulsen, C Fondy, et al.
Pharmacology|January 1, 1975
Similarity in cns sensitivity to hexobarbital in the rat and mouse as determined by an analytical, a pharmacokinetic, and an electroencephalographic measureR C Schnell, R E Stoll, R E Johnston, et al.
Therapie|March 1, 1984
[Oral administration of heparin and low molecular weight heparin fractions in rabbits]C Doutremepuich, F Toulemonde, M C Kuttler, et al.
Veterinary Research|January 1, 1995
Surface bacterial antigen CS31A as a tool to design new recombinant vaccines displaying heterologous antigenic determinantsC Martin, J P Girardeau, M Der Vartanian, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1993
Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonistC Cazaubon, J Gougat, F Bousquet, et al.
Journal of Medicinal Chemistry|February 14, 1997
Chromophore-modified bis-naphthalimides: synthesis and antitumor activity of bis-dibenz[de,h]isoquinoline-1,3-dionesM F Braña, J M Castellano, D Perron, et al.
Cancer Research|March 1, 1995
Preclinical evaluation of LU 79553: a novel bis-naphthalimide with potent antitumor activityP F Bousquet, M F Braña, D Conlon, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2007
Synthesis and biological evaluation of 5-substituted 1,4-dihydroindeno[1,2-c]pyrazoles as multitargeted receptor tyrosine kinase inhibitorsIrini Akritopoulou-Zanze, Daniel H Albert, Peter F Bousquet, et al.
Anti-Cancer Drug Design|June 1, 1996
Bis-naphthalimides 3: synthesis and antitumor activity of N,N'-bis[2-(1,8-naphthalimido)-ethyl] alkanediaminesM F Braña, J M Castellano, M Morán, et al.
Journal of Neuroimmunology|April 7, 2009
Distinct spatiotemporal pattern of CNS lesions revealed by USPIO-enhanced MRI in MOG-induced EAE rats implicates the involvement of spino-olivocerebellar pathwaysChih-Liang Chin, Madhavi Pai, Peter F Bousquet, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Cancer Research|March 1, 1990
Effects of cytochalasin B in culture and in vivo on murine Madison 109 lung carcinoma and on B16 melanomaP F Bousquet, L A Paulsen, C Fondy, et al.
Pharmacology|January 1, 1975
Similarity in cns sensitivity to hexobarbital in the rat and mouse as determined by an analytical, a pharmacokinetic, and an electroencephalographic measureR C Schnell, R E Stoll, R E Johnston, et al.
Therapie|March 1, 1984
[Oral administration of heparin and low molecular weight heparin fractions in rabbits]C Doutremepuich, F Toulemonde, M C Kuttler, et al.
Veterinary Research|January 1, 1995
Surface bacterial antigen CS31A as a tool to design new recombinant vaccines displaying heterologous antigenic determinantsC Martin, J P Girardeau, M Der Vartanian, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1993
Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonistC Cazaubon, J Gougat, F Bousquet, et al.
Journal of Medicinal Chemistry|February 14, 1997
Chromophore-modified bis-naphthalimides: synthesis and antitumor activity of bis-dibenz[de,h]isoquinoline-1,3-dionesM F Braña, J M Castellano, D Perron, et al.
Cancer Research|March 1, 1995
Preclinical evaluation of LU 79553: a novel bis-naphthalimide with potent antitumor activityP F Bousquet, M F Braña, D Conlon, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2007
Synthesis and biological evaluation of 5-substituted 1,4-dihydroindeno[1,2-c]pyrazoles as multitargeted receptor tyrosine kinase inhibitorsIrini Akritopoulou-Zanze, Daniel H Albert, Peter F Bousquet, et al.
Anti-Cancer Drug Design|June 1, 1996
Bis-naphthalimides 3: synthesis and antitumor activity of N,N'-bis[2-(1,8-naphthalimido)-ethyl] alkanediaminesM F Braña, J M Castellano, M Morán, et al.
Journal of Neuroimmunology|April 7, 2009
Distinct spatiotemporal pattern of CNS lesions revealed by USPIO-enhanced MRI in MOG-induced EAE rats implicates the involvement of spino-olivocerebellar pathwaysChih-Liang Chin, Madhavi Pai, Peter F Bousquet, et al.
Pageof 8